postpartum depression

Our medical roundtable examines the latest health headlines, including a drug for postpartum depression, stroke care, a gas station expanding into health care and full body MRIs.

Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.

The FDA granted approval of Zurzuvae for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.

Fifteen states haven’t moved to extend Medicaid coverage for new moms beyond the minimum of 60 days. But at least four are expected to consider proposals in upcoming legislative sessions.

An influential expert panel recommends pregnant women at risk of depression get referred to counseling to prevent the illness. But for many women and their doctors, it may be easier said than done.

California's legislature will soon take up a bill requiring doctors to screen new mothers. Many doctors oppose the idea, and similar laws elsewhere haven't increased the number of moms treated.

A package of mental health bills in California aims to make it easier for new moms to get help and to build awareness among more health workers of postpartum mood disorders.

This week is Perinatal Mental Health Awareness Week. Officials want to make people more aware of one of the top health complications surrounding...

Researchers aren't sure exactly why certain women are more vulnerable to postpartum depression. But authors of a new study are recommending that all pregnant women and new mothers be screened for depression.